$ 474.46
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Overvalued vs peers
About
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections...
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, overpriced
Target Price
The average target price of TMO is 556 and suggests 16% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
